Surgical aortic valve replacement in Australia, 2002-2015: temporal changes in clinical practice, patient profiles and outcomes.
aortic stenosis
surgical aortic valve replacement
time trend
Journal
ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
04
07
2018
revised:
19
03
2019
accepted:
20
06
2019
pubmed:
16
8
2019
medline:
2
10
2020
entrez:
16
8
2019
Statut:
ppublish
Résumé
This study describes the temporal changes in risk profiles and outcomes among patients with aortic stenosis (AS) undergoing surgical aortic valve replacement (SAVR) in Australia between 2002 and 2015. Using the Australian and New Zealand Society of Cardiac and Thoracic Surgeons database, we identified first-recorded SAVR for AS over 14 years. Patients' surgical risk profiles, procedures, 30-day and 12-month outcomes were summarized before and after the introduction of transcatheter aortic valve implantation in Australia, in 2008. We applied multivariable regression models to investigate the changes over time on risk-adjusted 30-day mortality, re-hospitalization and 12-month mortality. We identify a total of 18 147 patients with AS who underwent SAVR; mostly men (64%) with a mean age of 72 years. The proportion of major cardiac surgeries devoted to SAVR increased from 14% in 2002 to 20% in 2015. More SAVRs were performed electively (80% in 2002 versus 86% in 2015), and the recipients were at lower surgical risk (mean multi-risk score 3.9% in 2002 versus 3.0% in 2015). The use of bioprosthetic aortic valves increased over time (67% in 2002 to 88% in 2015). We found no significant changes in 30-day mortality, a significant decrease in 30-day readmission and minor fluctuations in 12-month mortality over the study period. SAVR comprises an increasingly larger proportion of all adult cardiac surgeries in Australia. There has been a greater use of bioprosthetic aortic valves, a fall in 30-day readmission but no significant changes in mortality.
Sections du résumé
BACKGROUND
This study describes the temporal changes in risk profiles and outcomes among patients with aortic stenosis (AS) undergoing surgical aortic valve replacement (SAVR) in Australia between 2002 and 2015.
METHODS
Using the Australian and New Zealand Society of Cardiac and Thoracic Surgeons database, we identified first-recorded SAVR for AS over 14 years. Patients' surgical risk profiles, procedures, 30-day and 12-month outcomes were summarized before and after the introduction of transcatheter aortic valve implantation in Australia, in 2008. We applied multivariable regression models to investigate the changes over time on risk-adjusted 30-day mortality, re-hospitalization and 12-month mortality.
RESULTS
We identify a total of 18 147 patients with AS who underwent SAVR; mostly men (64%) with a mean age of 72 years. The proportion of major cardiac surgeries devoted to SAVR increased from 14% in 2002 to 20% in 2015. More SAVRs were performed electively (80% in 2002 versus 86% in 2015), and the recipients were at lower surgical risk (mean multi-risk score 3.9% in 2002 versus 3.0% in 2015). The use of bioprosthetic aortic valves increased over time (67% in 2002 to 88% in 2015). We found no significant changes in 30-day mortality, a significant decrease in 30-day readmission and minor fluctuations in 12-month mortality over the study period.
CONCLUSION
SAVR comprises an increasingly larger proportion of all adult cardiac surgeries in Australia. There has been a greater use of bioprosthetic aortic valves, a fall in 30-day readmission but no significant changes in mortality.
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1061-1067Informations de copyright
© 2019 Royal Australasian College of Surgeons.
Références
Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on valvular heart disease. Eur. Heart J. 2003; 24: 1231-43.
Andell P, Li X, Martinsson A et al. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study. Heart 2017; 103: 1696-703.
Carabello BA, Paulus WJ. Aortic stenosis. Lancet 2009; 373: 956-66.
De Sciscio P, Brubert J, De Sciscio M, Serrani M, Stasiak J, Moggridge GD. Quantifying the shift toward transcatheter aortic valve replacement in low-risk patients. Circ. Cardiovasc. Qual. Outcomes 2017; 10: e003287.
De Sciscio P, Brubert J, De Sciscio M. Aortic stenosis in Australia: disease prevalence and patient eligibility for aortic valve replacement. Heart Lung Circ. 2015; 24: S409.
Bach DS, Siao D, Girard SE, Duvernoy C, McCallister BD Jr, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ. Cardiovasc. Qual. Outcomes 2009; 2: 533-9.
Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis. Circulation 2002; 106: 3006-8.
Walters DL, Webster M, Pasupati S et al. Position statement for the operator and institutional requirements for a transcatheter aortic valve implantation (TAVI) program. Heart Lung Circ. 2015; 24: 219-23.
Reid CM, Rockell M, Skillington PD et al. Initial twelve months experience and analysis for 2001-2002 from the Australasian Society of Cardiac and Thoracic Surgeons-Victorian database project. Heart Lung Circ. 2004; 13: 291-7.
Billah B, Reid CM, Shardey GC, Smith JA. A preoperative risk prediction model for 30-day mortality following cardiac surgery in an Australian cohort⋆. Eur. J. Cardiothorac. Surg. 2010; 37: 1086-92.
Cohn LH, Narayanasamy N. Aortic valve replacement in elderly patients: what are the limits? Curr. Opin. Cardiol. 2007; 22: 92-5.
Barreto-Filho JA, Wang Y, Dodson JA et al. Trends in aortic valve replacement for elderly patients in the United States, 1999-2011. JAMA 2013; 310: 2078-84.
Reid C, Billah B, Dinh D et al. An Australian risk prediction model for 30-day mortality after isolated coronary artery bypass: the AusSCORE. J. Thorac. Cardiovasc. Surg. 2009; 138: 904-10.
Australian Institute of Health and Walfare. Procedures data cubes for 2000-01 to 2014-2015 Australian Institute of Health and Walfare: Australian Government; 2017. [Cited 18 Aug 2017.] Available from URL: http://www.aihw.gov.au/hospitals-data/procedures-data-cubes/
De Backer O, Luk NHV, Olsen NT, Olsen PS, Sondergaard L. Choice of treatment for aortic valve stenosis in the era of transcatheter aortic valve replacement in eastern Denmark (2005 to 2015). JACC Cardiovasc. Interv. 2016; 9: 1152-8.
Nishimura RA, Otto CM, Bonow RO et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017; 135: e1159-95.
Rodriguez-Gabella T, Voisine P, Puri R, Pibarot P, Rodés-Cabau J. Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration. J. Am. Coll. Cardiol. 2017; 70: 1013-28.
Fuchs C, Mascherbauer J, Rosenhek R et al. Gender differences in clinical presentation and surgical outcome of aortic stenosis. Heart 2010; 96: 539-45.
Badhwar V, Rankin JS, Jacobs JP et al. The Society of Thoracic Surgeons adult cardiac surgery database: 2016 update on research. Ann. Thorac. Surg. 2016; 102: 7-13.
Onorati F, D'Errigo P, Barbanti M et al. Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: results of the multicenter Italian OBSERVANT registry. J. Thorac. Cardiovasc. Surg. 2014; 147: 1529-39.